United States · Seed startup

Who invested in Aperiam Bio

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$9.0Mraised across 1 round since 2023, from 1 source

Latest round
Seed, $9.0MNov 2023
Investors
1
See who backed them

The rounds

  1. Nov 2023
    Seed$9.0M

    Source recordedSEC filing: $4.0M sold, first sale Sept 2023

Everyone who backed them

KdT VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Aperiam Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Civilization VenturesVC firmPer its own site

Quick answers about Aperiam Bio

Who invested in Aperiam Bio?

Aperiam Bio's investors include KdT Ventures.

How much has Aperiam Bio raised?

Aperiam Bio has raised $9.0M across 1 round since 2023.

When did Aperiam Bio last raise?

Aperiam Bio's most recent round was a Seed of $9.0M in Nov 2023.

What was Aperiam Bio's biggest round?

Its most recent round, $9.0M in Nov 2023, is also its largest on record.

Who backed Aperiam Bio first?

Aperiam Bio's first round on record, in Nov 2023, was backed by KdT Ventures.

What stage is Aperiam Bio at?

Aperiam Bio's latest named round is a Seed, in Nov 2023.

Where is Aperiam Bio based?

Aperiam Bio is based in the United States.

Companies like Aperiam Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.